IMNM
Immunome Inc
22.30$
-7.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | |
| 4.7% | 6.7% | 25.6% | 28.5% | 19.6% | 21.7% | 24.8% | 17.9% | – | – | – | – | – | |
| 95.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 82.1% | – | – | – | – | – | |
| 107.2% | 251.9% | 1,493.6% | 1,230.2% | 1,278.4% | 1,749.1% | 1,260.2% | 1,007.5% | – | – | – | – | – | |
| 122.7% | 210.1% | 583.6% | 295.2% | 327.4% | 381.5% | 365.3% | 250.1% | – | – | – | – | – | |
| 225.3% | 2,573.9% | 12,957.0% | 1,792.4% | 1,836.2% | 3,130.3% | 1,625.5% | 1,239.7% | – | – | – | – | – | |
| -130.0% | -2,473.9% | -12,857.0% | -1,692.4% | -1,736.2% | -3,030.3% | -1,525.5% | -1,157.6% | – | – | – | – | – | |
| – | 5.3% | – | – | – | – | – | – | – | – | – | – | – | |
| -121.9% | -2,421.2% | -12,584.3% | -1,528.0% | -1,618.6% | -2,930.9% | -1,423.1% | -1,080.9% | – | – | – | – | – | |
| -4.7% | 9.6% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| -121.9% | -2,421.2% | -12,584.3% | -1,528.0% | -1,618.6% | -2,930.9% | -1,423.1% | -1,080.9% | – | – | – | – | – | |
| -117.2% | -355.3% | -1,951.6% | -1,397.0% | -1,486.1% | -2,008.9% | -1,398.3% | -1,062.9% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.